Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avandamet in Non-Diabetic Stable Coronary Syndromes
NCT00343395Phase 4Terminated
- Sponsor
- Intermountain Health
- Start
- Jun 2006
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rosiglitazone in coronary artery disease (CAD), sponsored by Intermountain Health. Started Jun 2006; status: terminated.
02
Drugs
rosiglitazone
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00343395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00343395.